Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management

@article{Scaroni2017GlucoseMA,
  title={Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management},
  author={Carla Scaroni and Marialuisa Zilio and Michelangelo Foti and Marco Boscaro},
  journal={Endocrine Reviews},
  year={2017},
  volume={38},
  pages={189–219}
}
An impaired glucose metabolism, which often leads to the onset of diabetes mellitus (DM), is a common complication of chronic exposure to exogenous and endogenous glucocorticoid (GC) excess and plays an important part in contributing to morbidity and mortality in patients with Cushing syndrome (CS). This article reviews the pathogenesis, epidemiology, diagnosis, and management of changes in glucose metabolism associated with hypercortisolism, addressing both the pathophysiological aspects and… Expand
The Effect of Pituitary Gland Disorders on Glucose Metabolism: From Pathophysiology to Management.
This review aims to explore, present, and discuss disorders of glucose metabolism implicated in pituitary gland diseases, the appropriate interventions, as well as the therapeutic challenges that mayExpand
Diabetes Mellitus Secondary to Cushing’s Disease
TLDR
This work examines the main features of DM secondary to Cushing’s disease and focuses on antidiabetic drugs and how cortisol-lowering medication affects glucose metabolism. Expand
Glucose metabolism in Cushing's syndrome.
  • A. Sharma, A. Vella
  • Medicine
  • Current opinion in endocrinology, diabetes, and obesity
  • 2020
TLDR
The recent advances in understanding the pathophysiology of diabetes mellitus from excess cortisol are understood to understand the effect on incretin secretion and action, gastric emptying, and its varied effect on adipose tissue. Expand
Glucose metabolism disorders in patients with adrenal gland disorders: pathophysiology and management
The aim of this review is to explore and discuss disorders of glucose metabolism that can arise in individuals with adrenal gland disorders, as well as to enumerate the available therapeuticExpand
Does glucocorticoid exposure explain the association between metabolic dysfunction and tendinopathy?
TLDR
This work highlights the role of glucocorticoids and how these hormones might underpin the connection between metabolic health and tendon dysfunction in the areas of visceral adiposity, dyslipidemia, insulin resistance and type 2 diabetes. Expand
Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing's syndrome.
TLDR
It is indicated that adrenalectomy for adrenal CS without overt DM may help ameliorate glucose metabolism disorders, and improve both insulin resistance and insulin secretion. Expand
The Quantitative Relationship Between Autonomous Cortisol Secretion, Dysglycemia and the Metabolic Syndrome.
TLDR
Post-DST cortisol should be viewed as a continuous parameter in risk stratification algorithms for the development of MS and particularly dysglycemia. Expand
Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities
TLDR
Greater awareness is needed among clinicians to help identify which patients should undergo biochemical screening for excess cortisol, and to review the biochemical screening tests and diagnosis for hypercortisolism associated with adrenal adenomas. Expand
Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess.
TLDR
The mal-effects of cortisol on cardiovascular and metabolic tissues are described and management strategies based on current largely observational data are discussed. Expand
Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice.
TLDR
Evidence is provided supporting the potential value of MR as a therapeutic target for conditions associated with metabolic syndrome by finding that both white and brown adipose depots form normally when compared with wild-type mice at P5. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 390 REFERENCES
Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome
TLDR
Gl glucocorticoid excess is able to impair insulin secretion as well as act at the level of the pancreatic beta cells, where it inhibits different steps of the insulin secretion process. Expand
Metabolic comorbidities in Cushing's syndrome.
TLDR
The metabolic comorbidities related to Cushing's syndrome and their management are summarized in the perspective of reducing the cardiovascular risk and mortality overall. Expand
Diabetes in Cushing syndrome: basic and clinical aspects
TLDR
This review focuses on the disorders of glucose metabolism in patients exposed to glucocorticoid excess, addressing both the pathophysiological aspects and the clinical and therapeutic implications. Expand
Pathophysiology of Dyslipidemia in Cushing’s Syndrome
TLDR
In humans, a high prevalence (up to 20%) of hepatic steatosis was also reported in patients with Cushing’s syndrome, and mice with a liver-specific disruption of the glucocorticoid receptor had diminished hepatic triglycerides levels. Expand
Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide.
TLDR
The epidemiology and pathophysiology of the disturbances of glucose metabolism that arise in Cushing's disease are summarized and recommendations for detecting and monitoring glucose abnormalities and for managing pasireotide-induced hyperglycaemia are proposed. Expand
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study
TLDR
The removal of aldosterone excess in APA patients induces the regression of both cardiac and gluco-metabolic complications, indicating ald testosterone as a main determinant of such alterations. Expand
Management of Diabetes Mellitus in Cushing’s Syndrome
TLDR
The most effective means of control of diabetes mellitus in a patient with active Cushing’s syndrome is to lower the levels of circulating cortisol, which may initially be achieved by using adrenal steroidogenesis blockade with drugs including metyrapone, ketaconazole, or, on occasion, mitotane. Expand
Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM.
TLDR
It is concluded that impaired glucose tolerance and/or diabetes in patients with endogenous Cushing syndrome is due to the hyperglycemic effects of cortisol with relative insulinopenia, which shares features with both the Metabolic Syndrome X and NIDDM, including impaired glucose uptake, hyperlipidemia and hypertension. Expand
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?
TLDR
Age, genetic predisposition and lifestyle, in combination with the duration and degree of hypercortisolism, strongly contribute to the impairment of glucose tolerance in patients with a natural history of Cushing's syndrome. Expand
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes.
TLDR
The implication of GC treatment on peripheral IR, islet function and glucose homeostasis is considered, which can result in hyperglycaemia, particularly in susceptible individuals. Expand
...
1
2
3
4
5
...